Contact:Cannabis Science, Inc.President and CEODr. Robert J. Melamede, 888-889-0888 email@example.comVP of Investor Relations Robert Kane, 561-234-6929 firstname.lastname@example.org www.cannabisscience.comSOURCE Cannabis Science, Inc.
The woes of anti-marijuana Attorney General Jeff Sessions are fueling speculative pot stock buying. But you should avoid these two high flying small fry.
Everyone else is doing it.
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.